Report Detail

Request for Sample of this report

Other Global Liposome Development Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4528047
    • |
  • 12 April, 2023
    • |
  • Global
    • |
  • 110 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

Liposomes are a type of nano-sized phospholipid bubbles, which have attracted much attention as potential drug carriers. Liposomes are highly biocompatible and easy to control in vivo and can be loaded with a broad variety of drugs, DNA, and diagnostic agents. To date, a variety of liposomal drugs are under development and some of them are already approved for clinical use.
According to our (Global Info Research) latest study, the global Liposome Development Service market size was valued at USD 1049.5 million in 2022 and is forecast to a readjusted size of USD 1765.6 million by 2029 with a CAGR of 7.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global key players of liposome development service include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, etc. The top two players hold a share over 52%. North America is the largest market, has a share about 61%, followed by Europe and Asia-Pacific, with share 26% and 11%, separately. In terms of product type, Lipid Nanoparticles is the largest segment, occupied for a share of 62%, and in terms of application, Commercial has a share about 86 percent.
This report is a detailed and comprehensive analysis for global Liposome Development Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Liposome Development Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Liposome Development Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Liposome Development Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Liposome Development Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Liposome Development Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Liposome Development Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences and Exelead, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Liposome Development Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Liposomes
Lipid Nanoparticles
Market segment by Application
Preclinical
Clinical
Commercial
Market segment by players, this report covers
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid
Polymun Scientific
Corden Pharma
Acuitas Therapeutics
Creative Biolabs
Creative Biostructure
T&T Scientific
FormuMax Scientific
PlantaCorp
CD Bioparticles
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Liposome Development Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liposome Development Service, with revenue, gross margin and global market share of Liposome Development Service from 2018 to 2023.
Chapter 3, the Liposome Development Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Liposome Development Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Liposome Development Service.
Chapter 13, to describe Liposome Development Service research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Liposome Development Service
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Liposome Development Service by Type
    • 1.3.1 Overview: Global Liposome Development Service Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Liposome Development Service Consumption Value Market Share by Type in 2022
    • 1.3.3 Liposomes
    • 1.3.4 Lipid Nanoparticles
  • 1.4 Global Liposome Development Service Market by Application
    • 1.4.1 Overview: Global Liposome Development Service Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Preclinical
    • 1.4.3 Clinical
    • 1.4.4 Commercial
  • 1.5 Global Liposome Development Service Market Size & Forecast
  • 1.6 Global Liposome Development Service Market Size and Forecast by Region
    • 1.6.1 Global Liposome Development Service Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Liposome Development Service Market Size by Region, (2018-2029)
    • 1.6.3 North America Liposome Development Service Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Liposome Development Service Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Liposome Development Service Market Size and Prospect (2018-2029)
    • 1.6.6 South America Liposome Development Service Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Liposome Development Service Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Precision NanoSystems
    • 2.1.1 Precision NanoSystems Details
    • 2.1.2 Precision NanoSystems Major Business
    • 2.1.3 Precision NanoSystems Liposome Development Service Product and Solutions
    • 2.1.4 Precision NanoSystems Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Precision NanoSystems Recent Developments and Future Plans
  • 2.2 Evonik
    • 2.2.1 Evonik Details
    • 2.2.2 Evonik Major Business
    • 2.2.3 Evonik Liposome Development Service Product and Solutions
    • 2.2.4 Evonik Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Evonik Recent Developments and Future Plans
  • 2.3 Merck KGaA
    • 2.3.1 Merck KGaA Details
    • 2.3.2 Merck KGaA Major Business
    • 2.3.3 Merck KGaA Liposome Development Service Product and Solutions
    • 2.3.4 Merck KGaA Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Merck KGaA Recent Developments and Future Plans
  • 2.4 Genevant Sciences
    • 2.4.1 Genevant Sciences Details
    • 2.4.2 Genevant Sciences Major Business
    • 2.4.3 Genevant Sciences Liposome Development Service Product and Solutions
    • 2.4.4 Genevant Sciences Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Genevant Sciences Recent Developments and Future Plans
  • 2.5 Exelead
    • 2.5.1 Exelead Details
    • 2.5.2 Exelead Major Business
    • 2.5.3 Exelead Liposome Development Service Product and Solutions
    • 2.5.4 Exelead Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Exelead Recent Developments and Future Plans
  • 2.6 Avanti Polar Lipids
    • 2.6.1 Avanti Polar Lipids Details
    • 2.6.2 Avanti Polar Lipids Major Business
    • 2.6.3 Avanti Polar Lipids Liposome Development Service Product and Solutions
    • 2.6.4 Avanti Polar Lipids Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Avanti Polar Lipids Recent Developments and Future Plans
  • 2.7 Nippon Fine Chemical
    • 2.7.1 Nippon Fine Chemical Details
    • 2.7.2 Nippon Fine Chemical Major Business
    • 2.7.3 Nippon Fine Chemical Liposome Development Service Product and Solutions
    • 2.7.4 Nippon Fine Chemical Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Nippon Fine Chemical Recent Developments and Future Plans
  • 2.8 Lipoid
    • 2.8.1 Lipoid Details
    • 2.8.2 Lipoid Major Business
    • 2.8.3 Lipoid Liposome Development Service Product and Solutions
    • 2.8.4 Lipoid Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Lipoid Recent Developments and Future Plans
  • 2.9 Polymun Scientific
    • 2.9.1 Polymun Scientific Details
    • 2.9.2 Polymun Scientific Major Business
    • 2.9.3 Polymun Scientific Liposome Development Service Product and Solutions
    • 2.9.4 Polymun Scientific Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Polymun Scientific Recent Developments and Future Plans
  • 2.10 Corden Pharma
    • 2.10.1 Corden Pharma Details
    • 2.10.2 Corden Pharma Major Business
    • 2.10.3 Corden Pharma Liposome Development Service Product and Solutions
    • 2.10.4 Corden Pharma Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Corden Pharma Recent Developments and Future Plans
  • 2.11 Acuitas Therapeutics
    • 2.11.1 Acuitas Therapeutics Details
    • 2.11.2 Acuitas Therapeutics Major Business
    • 2.11.3 Acuitas Therapeutics Liposome Development Service Product and Solutions
    • 2.11.4 Acuitas Therapeutics Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Acuitas Therapeutics Recent Developments and Future Plans
  • 2.12 Creative Biolabs
    • 2.12.1 Creative Biolabs Details
    • 2.12.2 Creative Biolabs Major Business
    • 2.12.3 Creative Biolabs Liposome Development Service Product and Solutions
    • 2.12.4 Creative Biolabs Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Creative Biolabs Recent Developments and Future Plans
  • 2.13 Creative Biostructure
    • 2.13.1 Creative Biostructure Details
    • 2.13.2 Creative Biostructure Major Business
    • 2.13.3 Creative Biostructure Liposome Development Service Product and Solutions
    • 2.13.4 Creative Biostructure Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Creative Biostructure Recent Developments and Future Plans
  • 2.14 T&T Scientific
    • 2.14.1 T&T Scientific Details
    • 2.14.2 T&T Scientific Major Business
    • 2.14.3 T&T Scientific Liposome Development Service Product and Solutions
    • 2.14.4 T&T Scientific Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 T&T Scientific Recent Developments and Future Plans
  • 2.15 FormuMax Scientific
    • 2.15.1 FormuMax Scientific Details
    • 2.15.2 FormuMax Scientific Major Business
    • 2.15.3 FormuMax Scientific Liposome Development Service Product and Solutions
    • 2.15.4 FormuMax Scientific Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 FormuMax Scientific Recent Developments and Future Plans
  • 2.16 PlantaCorp
    • 2.16.1 PlantaCorp Details
    • 2.16.2 PlantaCorp Major Business
    • 2.16.3 PlantaCorp Liposome Development Service Product and Solutions
    • 2.16.4 PlantaCorp Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 PlantaCorp Recent Developments and Future Plans
  • 2.17 CD Bioparticles
    • 2.17.1 CD Bioparticles Details
    • 2.17.2 CD Bioparticles Major Business
    • 2.17.3 CD Bioparticles Liposome Development Service Product and Solutions
    • 2.17.4 CD Bioparticles Liposome Development Service Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 CD Bioparticles Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Liposome Development Service Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Liposome Development Service by Company Revenue
    • 3.2.2 Top 3 Liposome Development Service Players Market Share in 2022
    • 3.2.3 Top 6 Liposome Development Service Players Market Share in 2022
  • 3.3 Liposome Development Service Market: Overall Company Footprint Analysis
    • 3.3.1 Liposome Development Service Market: Region Footprint
    • 3.3.2 Liposome Development Service Market: Company Product Type Footprint
    • 3.3.3 Liposome Development Service Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Liposome Development Service Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Liposome Development Service Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Liposome Development Service Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Liposome Development Service Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Liposome Development Service Consumption Value by Type (2018-2029)
  • 6.2 North America Liposome Development Service Consumption Value by Application (2018-2029)
  • 6.3 North America Liposome Development Service Market Size by Country
    • 6.3.1 North America Liposome Development Service Consumption Value by Country (2018-2029)
    • 6.3.2 United States Liposome Development Service Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Liposome Development Service Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Liposome Development Service Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Liposome Development Service Consumption Value by Type (2018-2029)
  • 7.2 Europe Liposome Development Service Consumption Value by Application (2018-2029)
  • 7.3 Europe Liposome Development Service Market Size by Country
    • 7.3.1 Europe Liposome Development Service Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Liposome Development Service Market Size and Forecast (2018-2029)
    • 7.3.3 France Liposome Development Service Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Liposome Development Service Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Liposome Development Service Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Liposome Development Service Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Liposome Development Service Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Liposome Development Service Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Liposome Development Service Market Size by Region
    • 8.3.1 Asia-Pacific Liposome Development Service Consumption Value by Region (2018-2029)
    • 8.3.2 China Liposome Development Service Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Liposome Development Service Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Liposome Development Service Market Size and Forecast (2018-2029)
    • 8.3.5 India Liposome Development Service Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Liposome Development Service Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Liposome Development Service Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Liposome Development Service Consumption Value by Type (2018-2029)
  • 9.2 South America Liposome Development Service Consumption Value by Application (2018-2029)
  • 9.3 South America Liposome Development Service Market Size by Country
    • 9.3.1 South America Liposome Development Service Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Liposome Development Service Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Liposome Development Service Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Liposome Development Service Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Liposome Development Service Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Liposome Development Service Market Size by Country
    • 10.3.1 Middle East & Africa Liposome Development Service Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Liposome Development Service Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Liposome Development Service Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Liposome Development Service Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Liposome Development Service Market Drivers
  • 11.2 Liposome Development Service Market Restraints
  • 11.3 Liposome Development Service Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Liposome Development Service Industry Chain
  • 12.2 Liposome Development Service Upstream Analysis
  • 12.3 Liposome Development Service Midstream Analysis
  • 12.4 Liposome Development Service Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Liposome Development Service. Industry analysis & Market Report on Liposome Development Service is a syndicated market report, published as Global Liposome Development Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Liposome Development Service market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,773.56
    		4,160.34
    		5,547.12
    		3,236.40
    		4,854.60
    		6,472.80
    		532,022.40
    		798,033.60
    		1,064,044.80
    		290,336.40
    		435,504.60
    		580,672.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo